Baiye Jin

450 total citations
21 papers, 297 citations indexed

About

Baiye Jin is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Baiye Jin has authored 21 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Baiye Jin's work include Bladder and Urothelial Cancer Treatments (9 papers), Urinary and Genital Oncology Studies (4 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Baiye Jin is often cited by papers focused on Bladder and Urothelial Cancer Treatments (9 papers), Urinary and Genital Oncology Studies (4 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Baiye Jin collaborates with scholars based in China, United States and Madagascar. Baiye Jin's co-authors include Guanghou Fu, Hao Pan, Zhijie Xu, Qi Zhang, Frank Luh, Anqi Chen, Zhijian Zhu, Yimin Wang, Xiyong Liu and Xiaofei Cheng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Analytica Chimica Acta.

In The Last Decade

Baiye Jin

19 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Baiye Jin China	9	178	85	68	57	36	21	297
Binbin Yin China	10	165 0.9×	79 0.9×	26 0.4×	72 1.3×	50 1.4×	19	337
Youguang Huang China	10	230 1.3×	132 1.6×	38 0.6×	86 1.5×	38 1.1×	20	353
Zhilei Zhang China	11	205 1.2×	139 1.6×	23 0.3×	37 0.6×	75 2.1×	25	393
Antoine Jalil France	8	158 0.9×	82 1.0×	75 1.1×	33 0.6×	35 1.0×	14	354
Qingfei Meng China	8	187 1.1×	135 1.6×	21 0.3×	29 0.5×	33 0.9×	12	305
Zihan Yi China	10	202 1.1×	141 1.7×	29 0.4×	54 0.9×	33 0.9×	17	297
Lili Yan China	11	181 1.0×	63 0.7×	38 0.6×	64 1.1×	48 1.3×	18	327
Haonan Wang China	11	173 1.0×	82 1.0×	21 0.3×	34 0.6×	39 1.1×	35	319
Wei‐Chen Yen Taiwan	6	179 1.0×	91 1.1×	29 0.4×	59 1.0×	35 1.0×	8	308

Countries citing papers authored by Baiye Jin

Since Specialization

Citations

This map shows the geographic impact of Baiye Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baiye Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baiye Jin more than expected).

Fields of papers citing papers by Baiye Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baiye Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baiye Jin. The network helps show where Baiye Jin may publish in the future.

Co-authorship network of co-authors of Baiye Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Baiye Jin. A scholar is included among the top collaborators of Baiye Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baiye Jin. Baiye Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sun, Rui, Jiang Peng, Binyuan Yan, et al.. (2025). DNA2 protein destruction dictates DNA hyperexcision, cGAS–STING activation, and innate immune response in CDK12-deregulated cancers. Proceedings of the National Academy of Sciences. 122(28). e2413732122–e2413732122.

Wu, Yunfei, Zhijie Xu, Yanfeng Bai, et al.. (2025). Prognostic biomarker PSMD14 facilitates bladder cancer tumorigenesis and progression by regulating Nucleolin-YAP1 axis. Translational Oncology. 55. 102370–102370. 1 indexed citations

You, Jung‐Min, Anqi Chen, Jing Qiu, et al.. (2025). On-chip single-cell mass spectrometry for streamlined metabolic exploration enabled by a reversibly-bonded microfluidic platform. Analytica Chimica Acta. 1376. 344608–344608.

Zhou, Feng, Haiping Wang, Kan Liu, et al.. (2024). Effectiveness, pharmacokinetics, and safety of triptorelin acetate microspheres in patients with locally advanced and metastatic prostate cancer. Therapeutic Advances in Medical Oncology. 16. 12752554–12752554. 1 indexed citations

Cheng, Cheng, Zhijie Xu, Xiaoyi Chen, et al.. (2024). NOP2-mediated 5-methylcytosine modification of APOL1 messenger RNA activates PI3K-Akt and facilitates clear cell renal cell carcinoma progression. International Journal of Biological Sciences. 20(12). 4853–4871. 8 indexed citations

Wu, Yunfei, et al.. (2024). Identification of tumor-antigen signatures and immune subtypes for messenger RNA vaccine selection in advanced clear cell renal cell carcinoma. Surgery. 176(3). 785–797. 1 indexed citations

Wu, Yunfei, et al.. (2024). Identification of a cisplatin resistant-based prognostic immune related gene signature in MIBC. Translational Oncology. 44. 101942–101942. 4 indexed citations

Wu, Yunfei, et al.. (2023). RCC1 functions as a tumor facilitator in clear cell renal cell carcinoma by dysregulating cell cycle, apoptosis, and EZH2 stability. Cancer Medicine. 12(19). 19889–19903. 5 indexed citations

Qi, Xiao-Ping & Baiye Jin. (2022). [The trends in early precision diagnosis and treatment strategies of multiple endocrine neoplasia type 2].. PubMed. 60(11). 973–980. 1 indexed citations

10.

Chen, Anqi, Jiaxin Feng, Lei Bi, et al.. (2021). Single Cell Mass Spectrometry With a Robotic Micromanipulation System for Cell Metabolite Analysis. IEEE Transactions on Biomedical Engineering. 69(1). 325–333. 10 indexed citations

11.

Fu, Guanghou, et al.. (2021). Population-based outcome of muscle-invasive bladder cancer following radical cystectomy: who can benefit from adjuvant chemotherapy?. Translational Andrology and Urology. 10(1). 356–373. 6 indexed citations

12.

Xu, Zhijie, Hemant Gujar, Guanghou Fu, et al.. (2021). A Novel DNA Methylation Signature as an Independent Prognostic Factor in Muscle-Invasive Bladder Cancer. Frontiers in Oncology. 11. 614927–614927. 8 indexed citations

13.

Fu, Guanghou, Anqi Chen, Zhijie Xu, et al.. (2021). Microfluidic Assaying of Circulating Tumor Cells and Its Application in Risk Stratification of Urothelial Bladder Cancer. Frontiers in Oncology. 11. 11 indexed citations

14.

Fu, Guanghou, et al.. (2020). Urinary exfoliated tumor single-cell metabolomics technology for establishing a drug resistance monitoring system for bladder cancer with intravesical chemotherapy. Medical Hypotheses. 143. 110100–110100. 5 indexed citations

15.

Wang, Ying, Haipeng Huang, Kezhen Shen, et al.. (2019). Role of TFEB in autophagic modulation of ischemia reperfusion injury in mice kidney and protection by urolithin A. Food and Chemical Toxicology. 131. 110591–110591. 31 indexed citations

16.

Xu, Zhijie, Zhijian Zhu, Anqi Chen, et al.. (2018). Modulation of G6PD affects bladder cancer via ROS accumulation and the AKT pathway in vitro. International Journal of Oncology. 53(4). 1703–1712. 62 indexed citations

17.

Chen, Anqi, Guanghou Fu, Zhijie Xu, et al.. (2018). Detection of Urothelial Bladder Carcinoma via Microfluidic Immunoassay and Single-Cell DNA Copy-Number Alteration Analysis of Captured Urinary-Exfoliated Tumor Cells. Cancer Research. 78(14). 4073–4085. 38 indexed citations

18.

Jin, Baiye, Guanghou Fu, Hao Pan, et al.. (2010). Anti-tumour efficacy of mitofusin-2 in urinary bladder carcinoma. Medical Oncology. 28(S1). 373–380. 56 indexed citations

19.

Jin, Xiaodong, et al.. (2008). Incidental prostate cancer in radical cystoprostatectomy specimens. Asian Journal of Andrology. 10(5). 809–814. 9 indexed citations

20.

Takahara, Takeshi, Kei Furui, Yutaka Yata, et al.. (1997). Dual expression of matrix protease -2 and membrane type I-matrix proteinase in fibrotic human livers. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact